Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 1/20 | 0.61 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.54 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 6/20 | 0.50 |
| ▸ | DPP9 | Q86TI2 | 6/20 | 0.50 |
| ▸ | DPP4 | P27487 | 4/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.42 |
| ▸ | RRM1 | P23921 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9825772 | 0.92 | SIGMAR1 (0.57) | METAP1DPP7SLC15A1LMNABLM | |
| SCHEMBL15623642 | 0.83 | METAP1 (0.58) | METAP1DPP7SLC15A1DPP8DPP9 | |
| SCHEMBL904231 | 0.83 | METAP1 (0.58) | METAP1DPP7SLC15A1DPP8DPP9 | |
| SCHEMBL6875880 | 0.81 | METAP1 (0.49) | METAP1DPP7SLC15A1LMNABLM | |
| SCHEMBL3411145 | 0.81 | METAP1 (0.49) | METAP1DPP7SLC15A1LMNABLM | |
| SCHEMBL6876305 | 0.81 | METAP1 (0.49) | METAP1DPP7SLC15A1LMNABLM | |
| SCHEMBL6876886 | 0.81 | METAP1 (0.49) | METAP1DPP7SLC15A1LMNABLM | |
| SCHEMBL2345431 | 0.81 | LMNA (0.49) | METAP1DPP7LMNABLMDPP8 | |
| SCHEMBL2345434 | 0.81 | LMNA (0.49) | METAP1DPP7LMNABLMDPP8 | |
| SCHEMBL27097194 | 0.81 | SIGMAR1 (0.44) | METAP1DPP7SLC15A1LMNABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11692008-B2 | Preparation and uses of reactive oxygen species scavenger derivatives | XWPharma Ltd. (KY) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11692008-B2 | Preparation and uses of reactive oxygen species scavenger derivatives | AIFM2, GPX1, GPX4 | METAP1 4026/4885DPP7 4560/4885SLC15A1 539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.